Armata Pharmaceuticals, Inc.
ARMP
$2.51
$0.083.29%
AMEX
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 341.75% | -60.24% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 341.75% | -60.24% | |||
| Cost of Revenue | -96.92% | -83.90% | |||
| Gross Profit | 140.54% | 84.80% | |||
| SG&A Expenses | -19.49% | -2.11% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.81% | -26.26% | |||
| Operating Income | 16.44% | 22.28% | |||
| Income Before Tax | -149.50% | -351.19% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -149.50% | -351.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -149.50% | -351.19% | |||
| EBIT | 16.44% | 22.28% | |||
| EBITDA | 17.10% | 23.08% | |||
| EPS Basic | -149.42% | -351.04% | |||
| Normalized Basic EPS | 10.16% | 14.29% | |||
| EPS Diluted | -128.18% | 62.35% | |||
| Normalized Diluted EPS | -47.69% | 14.85% | |||
| Average Basic Shares Outstanding | 0.02% | 0.00% | |||
| Average Diluted Shares Outstanding | -39.15% | 0.67% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||